2025 BIO International Recap
June 19, 2025
BioUtah and its Utah consortium made their mark this week at the BIO International Conference, hosting a Utah Pavillion to promote the state’s fast-growing life sciences industry. The conference, held in Boston, MA. drew appproximately 20,000 attendees. The Utah delegation included BioUtah, Utah life sciences companies, the Governor’s Office of Economic Development, the Unversity of Utah’s Technology Licensing Office, EDCUtah and the Utah World Trade Center. The Pavillion provided an exceptional opportunity to showcase Utah’s dynamic biotech community to a large audience from across the nation and across the globe.
“The conference provided a forum to raise the profile of Utah’s growing pharma sector and make valuable connections,” said Kelvyn Cullimore, president and CEO of BioUtah, who was on hand for the event. “The sessions provided insights on relevant topics and the Utah exhibit helped broadcast to conference-goers our innovation story.”
A number of Utah companies in attendance included:
- Halia Therapeutics
- Biolexis Therapeutics
- Curza
- Clene Nanomedicine
- Renew Biotechnologies
- 3Helix
Recent News
- Freyya Closes Oversubscribed Pre-Seed Financing to Advance FDA Regulatory Milestones, Commercialization
- In Memory of Dr. Michael Rinck, Founder, MT Promedt Consulting GmbH
- bioMérieux Launches SPINCHIP® hs-cTnl, a Major Innovation for the Measurement of High-Sensitivity Cardiac Troponin I and Faster Management of Cardiac Emergencies
- Priority Review Granted for PolarityBio’s SkinTE for Treatment of Diabetic Foot Ulcers
- National Institutes of Health Award Inherent Biosciences a Direct-to-Phase II SBIR Grant
- Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation
